Innovations_in_Molecular_Mechanisms_and_Tissue_Engineering_(Stem_Cell_Biology_and_Regenerative_Medicine)

(Brent) #1
89

epidermis, (2) endothelial cells contribute only to the vasculature of the regenerate,


(3) osteoblasts precursors of the limb give rise only to regenerated bone, and (4) as


a negative result, transplanted hematopoietic stem cells do not contribute to the


regenerate. These fi nding are consistent with the conclusion that cells involved in


the regeneration of the urodele limb are lineage-restricted [ 29 ], so it is tempting to


draw the general conclusion that the regeneration process does not involve the re-


programming of cell types [ 18 , 27 ]. Yet, it is important to point out that a number of


cell types have yet to be carefully tested and there is considerable evidence that


support the participation of multipotent progenitor cells in other injury repair mod-


els [ 30 ]. The question of whether progenitor cells arise from a population of stem


cells versus the de-differentiation of mature cells has yet to be addressed in this


mammalian regenerative response.


The second critical question to address involves how cells are recruited to form

the blastema at the amputation wound site. During regeneration, cells migrate from


different regions of the amputation wound to form the centrally located blastema


[ 31 , 32 ]. Previous studies have implicated Stromal Cell Derived Factor-1 (SDF-



  1. / CXCR4 signaling in the cellular recruitment to sites of BMP2 -induced ectopic


bone formation, bone repair, and zebrafi sh fi n regeneration [ 33 – 35 ]. A comprehen-


sive study investigating the role of SDF- 1 / CXCR4 signaling in blastema formation


and digit regeneration was carried out [ 36 ] and a summary of this study follows.


Immunohistochemical and in situ hybridization studies focused on the regenerating


digit identifi ed cells expressing SDF- 1 in the blastema, wound epidermis, and bone


marrow vasculature, and other cells expressing CXCR4 in the wound epidermis and


within the blastema (Fig. 5.4a–d ). Immunostaining for Phospho-CXCR4, used to


identify the SDF-1 mediated activation of CXCR4, showed positive signal localized


to the wound epidermis and the vasculature proximal to the blastema (Fig. 5.4e ). In


line with this, CD31+ endothelial cells within the blastema tested immunopositive


for SDF- 1 , suggesting endothelial cells may function in cellular recruitment during


regeneration (Fig. 5.4f ). Primary cultures of blastema cells express CXCR4 and


display a dose-dependent response to SDF1 in transwell migration assays that is


inhibited by AMD3100, a known antagonist for CXCR4 signaling. To test the


in vivo role of SDF-1/CXCR4 signaling in neonatal digit regeneration, systemic


injections of AMD3100 resulted in a signifi cant attenuation in regenerated bone


length compared to vehicle control treated digits (Fig. 5.4g ). Importantly, no differ-


ence was found in bone length of the developing P3 digit after AMD3100 systemic


treatment, providing evidence that SDF- 1 / CXCR4 signaling is specifi c to the regen-


eration response. The BMP2 -induced regeneration response was used to provide a


gain of function test for a role of SDF1 recruitment in regeneration. First, introduc-


ing labeled blastema cells in conjunction with a BMP2 bead resulted in a chemotactic


response with labeled cells aggregating around the BMP2 source. Transwell migra-


tion assays demonstrated that BMP2 itself does not infl uence blastema cell migra-


tion indicating that the in vivo response was indirect. BMP2 treatment of P2


amputations was found to induce both SDF- 1 and CXCR4 expression and SDF-1


expression co-localized with endothelial cells in the amputation wound (Fig. 5.4h–


m ). A BMP2/SDF-1 link was confi rmed in vitro by studies showing that BMP2


5 Digit Regeneration in Mammals


http://www.ebook3000.com
Free download pdf